M3, Inc. (2413.T)
- Previous Close
1,904.50 - Open
1,958.00 - Bid 1,902.50 x --
- Ask 1,905.00 x --
- Day's Range
1,895.00 - 1,971.00 - 52 Week Range
1,126.50 - 2,047.00 - Volume
7,974,600 - Avg. Volume
5,281,581 - Market Cap (intraday)
1.292T - Beta (5Y Monthly) 0.94
- PE Ratio (TTM)
31.92 - EPS (TTM)
59.61 - Earnings Date Jul 24, 2025 - Jul 28, 2025
- Forward Dividend & Yield 42.00 (2.21%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
2,045.83
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists, recruitment, and posting job advertisements through m3.com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. Further, M3, Inc. offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
corporate.m3.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 2413.T
View MorePerformance Overview: 2413.T
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2413.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2413.T
View MoreValuation Measures
Market Cap
1.29T
Enterprise Value
1.15T
Trailing P/E
31.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.54
Price/Book (mrq)
3.42
Enterprise Value/Revenue
4.04
Enterprise Value/EBITDA
14.81
Financial Highlights
Profitability and Income Statement
Profit Margin
14.21%
Return on Assets (ttm)
7.03%
Return on Equity (ttm)
11.38%
Revenue (ttm)
284.9B
Net Income Avi to Common (ttm)
40.48B
Diluted EPS (ttm)
59.61
Balance Sheet and Cash Flow
Total Cash (mrq)
134.93B
Total Debt/Equity (mrq)
5.92%
Levered Free Cash Flow (ttm)
40.37B